Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Shilipi
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Changing Demography of Pancreatitis Patients in India -A Hospital Based Study
Pancreatitis is rising globally, with major risk factors including alcohol, tobacco, and family history. A study of 800 patients in North India found higher incidences among non-alcoholic, non-tobacco users, and those with no family history. The disease mostly affected men (4.6:1) aged 19-45, particularly in the service class and students. Further research is needed to explore its causes and extent in the region.
Immunomodulatory Effects of a Herbo-Mineral Ayurvedic Formulation in Experimental Models
IMMBO, a herbo-mineral Ayurvedic formulation, shows promise as an immune-modulator in immunosuppressed rats. It enhances immunity, blocks histamine release, and modulates key molecules like TNF-α and NF-κB, offering potential for allergic and immune-related disorders.
Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District
This study evaluated the effect of Ayurvedic preparations Sootshekhar Rasa (SR) and Sitopaladi Churna (SC) with iron and folic acid (IFA) on nutritional anaemia in 820 adolescents in Dehradun, India. After 90 days of treatment, all groups showed increased haemoglobin levels, with the best results in the group receiving SR + SC + IFA. No major side effects were reported, and the treatment led to sustainable improvements in anaemia.
Transformation of Copper into therapeutic mineral complex following principles of Rasa Shastra
Rasa Shastra, an Ayurvedic branch, transforms toxic substances into safe therapeutics. A compound using Copper, Mercury, Sulphur, Luffa echinata, Clitoria ternatea, and lemon juice was effective in treating pancreatic disorders. The 2015-17 study developed standard procedures and analyzed the compound, revealing new mineral forms and no free metals. This demonstrates the potential of traditional methods in safely converting metals into effective treatments.
Relevance of metal based Ayurvedic formulations in the management of recurrent acute/ chronic pancreatitis
This study reports on 250 cases of Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP) treated with an Ayurvedic herbo-mineral formulation, along with a balanced diet and lifestyle changes. Significant improvement was seen in patients who completed the treatment.
Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial
A study on 250 patients compared the Ayurvedic formulation IMMBO to a levocetirizine-montelukast combination for allergic rhinitis. IMMBO showed significantly greater improvements in symptoms (TNSS: -5.70 vs. -3.31) and IgE reduction (-351.54 vs. -208.79), demonstrating superior efficacy and safety.